Viewing Study NCT00201994

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:39 AM
Ignite Modification Date: 2026-01-25 @ 1:49 AM
Study NCT ID: NCT00201994
Status: COMPLETED
Last Update Posted: 2012-05-03
First Post: 2005-09-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: "SALT-2 Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hyponatremia View
None Water Intoxication View
None Inappropriate ADH Syndrome View
None Water-electrolyte Imbalance View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Sodium View
None SIADH View
None Vasopressin View
None CHF View
None Cirrhosis View
None salt View
None water View
None electrolyte View